SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for IDEXX LABORATORIES (IDXX) — Feb 12, 2008

IDEXX LABORATORIES INC /DE (IDXX) (CIK 0000874716)
Date: Feb. 12, 2008 · CIK: 0000874716 · Accession: 0000000000-08-007782

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 000-19271

Date
February 12, 2008
Author
Tim Buchmiller
Form
UPLOAD
Company
IDEXX LABORATORIES INC /DE (IDXX) (CIK 0000874716)

Letter

Mail Stop 6010 February 12, 2008 Conan R. Deady Corporate Vice President and General Counsel IDEXX Laboratories, Inc. One IDEXX Drive Westbrook, ME 04092 Re: IDEXX Laboratories, Inc. Definitive Proxy Statement Filed March 29, 2007 File No. 000-19271 Dear Mr. Deady: We have completed our review of your executive compensation and related disclosure and have no further comments at this time. Please note that the company is responsib le for the adequacy and accuracy of the disclosure in its filing. We are not approving any proposed disclosure you may have included in your response lette r or any disclosure you include in your future filings in response to our comments. If you have any further questions regardi ng our review of your filing, please call me at (202) 551-3635. S i n c e r e l y , T i m B u c h m i l l e r S e n i o r A t t o r n e y

Show Raw Text
Mail Stop 6010
  February 12, 2008
 Conan R. Deady
Corporate Vice President and General Counsel
IDEXX Laboratories, Inc. One IDEXX Drive Westbrook, ME 04092
Re: IDEXX Laboratories, Inc.  Definitive Proxy Statement
Filed March 29, 2007
 File No. 000-19271
 Dear Mr. Deady:
We have completed our review of your executive compensation and related
disclosure and have no further comments at this time.
Please note that the company is responsib le for the adequacy and accuracy of the
disclosure in its filing.  We  are not approving any proposed  disclosure you may have
included in your response lette r or any disclosure you include in your future filings in
response to our comments.
If you have any further questions regardi ng our review of your filing, please call
me at (202) 551-3635.          S i n c e r e l y ,             T i m  B u c h m i l l e r          S e n i o r  A t t o r n e y